PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
1.90 - 2.15
0.48 - 2.54
9.88M / 3.06M (Avg.)
-0.59 | -3.40
Shows the trajectory of a company's cash-generation capacity. Consistent growth in operating and free cash flow suggests a robust, self-funding business model—crucial for value investors seeking undervalued, cash-rich opportunities.
8165.71%
Net income growth above 1.5x CRON.TO's 713.40%. David Dodd would see a clear bottom-line advantage if it is backed by stable operations.
86.48%
D&A growth well above CRON.TO's 81.80%. Michael Burry would suspect heavier depreciation burdens that might erode net income unless top-line follows suit.
-212289.86%
Both lines show negative yoy. Martin Whitman would see an industry or cyclical factor reducing tax deferrals for both players.
-47.10%
Both cut yoy SBC, with CRON.TO at -97.63%. Martin Whitman would view it as an industry shift to reduce stock-based pay or a sign of reduced expansions.
69.98%
Well above CRON.TO's 10.65% if positive yoy. Michael Burry would see a risk of bigger working capital demands vs. competitor, harming free cash flow.
155.25%
AR growth while CRON.TO is negative at -595.39%. John Neff would note competitor possibly improving working capital while we allow AR to rise.
-2448.29%
Both reduce yoy inventory, with CRON.TO at -2234.76%. Martin Whitman would find a widespread caution or cyclical demand drop in the niche.
-12566.83%
Negative yoy AP while CRON.TO is 111.40%. Joel Greenblatt would see quicker payments or less reliance on trade credit than competitor, unless expansions are hindered.
1768.63%
Some yoy usage while CRON.TO is negative at -276.36%. John Neff would see competitor possibly generating more free cash from minor accounts than we do.
-143.57%
Both negative yoy, with CRON.TO at -4.78%. Martin Whitman would suspect an overall environment of intangible cleanup or shifting revaluations for the niche.
189.60%
Operating cash flow growth above 1.5x CRON.TO's 43.82%. David Dodd would confirm superior cost control or stronger revenue-to-cash conversion.
45.39%
Some CapEx rise while CRON.TO is negative at -1066.85%. John Neff would see competitor possibly building capacity while we hold back expansions.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
292.16%
Growth well above CRON.TO's 155.77%. Michael Burry would suspect heavier intangible or side spending overshadowing competitor’s approach, risking short-term FCF.
-87.26%
We reduce yoy invests while CRON.TO stands at 89.41%. Joel Greenblatt sees near-term liquidity advantage unless competitor’s expansions yield high returns.
No Data
No Data available this quarter, please select a different quarter.
-96.78%
Both yoy lines negative, with CRON.TO at -102.65%. Martin Whitman suspects an environment or preference for internal financing over new equity in the niche.
No Data
No Data available this quarter, please select a different quarter.